Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Irene, Gerlach"'
Autor:
Irene Gerlach, Corinna Schein
Publikováno v:
Teilzeitführung ISBN: 9783658401252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4e68d729af6b3e9437bfb02aab4cf4e
https://doi.org/10.1007/978-3-658-40126-9_10
https://doi.org/10.1007/978-3-658-40126-9_10
Autor:
Jörg M. Fegert, Irene Gerlach
Publikováno v:
Sozialer Fortschritt. 69:495-510
Zusammenfassung Der vorliegende Beitrag bietet einen Überblick auf die lange, wechselvolle Geschichte des Wissenschaftlichen Beirats für Familienfragen, die von unterschiedlichen Phasen der Beratungstätigkeit mit jeweils auch unterschiedlicher Koo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::293d105be3b8987608c4e2aa4aa874c7
https://doi.org/10.3790/sfo.69.8-9.495
https://doi.org/10.3790/sfo.69.8-9.495
Autor:
Michael Reutlinger, Georg Schmitt, Roland Jakob-Roetne, Anja Limberg, Hasane Ratni, Werner Neidhart, Solen Pichereau, Caterina Bissantz, Karlheinz Baumann, Rosa-Maria Rodriguez-Sarmiento, Mingqiu Lu, Bjoern Bartels, Irene Gerlach, André Alker, Eric Zhang, Chen Weichun
Publikováno v:
ACS Med Chem Lett
[Image: see text] γ-Secretase (GS) is a key target for the potential treatment of Alzheimer’s disease. While inhibiting GS led to serious side effects, its modulation holds a lot of potential to deliver a safe treatment. Herein, we report the disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794566175e39407157febc7ccb1d38a9
https://doi.org/10.1021/acsmedchemlett.0c00109
https://doi.org/10.1021/acsmedchemlett.0c00109
Publikováno v:
Neurobiology of Disease, Vol 23, Iss 1, Pp 77-86 (2006)
Excitotoxicity-mediated cell death is involved in Parkinson's disease (PD). 5-HT1A receptor agonists can protect from such mechanisms. The current study demonstrates that the 5-HT1A agonists BAY 639044 and repinotan have neuroprotective effects in a
Externí odkaz:
https://doaj.org/article/2ee4aa71c51b4daa84382af4db728c31
Autor:
Irene Gerlach
Publikováno v:
Zeitschrift für Sozialreform. 64:121-128
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4da81d29c4e3137ab5bb7107a751f094
https://doi.org/10.1515/zsr-2018-0008
https://doi.org/10.1515/zsr-2018-0008
Autor:
Paul Delmar, Juha-Matti Savola, Stephane Nave, Inma Gilaberte, Paulo Fontoura, Tania Nikolcheva, Marie Mannino, Meike Pauly-Evers, Juergen Dukart, Timo Grimmer, Benedicte Ricci, Nicoletta Milani Muelhardt, Tracie Carey, Irene Gerlach, Edilio Borroni, Rachelle S. Doody, Mercè Boada, Luca Santarelli, Christian Czech, Susanne Ostrowitzki, Emma Moran
Publikováno v:
Journal of Alzheimer's Disease
Background: Sembragiline is a potent, selective, long-acting, and reversible MAO-B inhibitor developed as a potential treatment for Alzheimer’s disease (AD). Objective: To evaluate the safety, tolerability, and efficacy of sembragiline in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37dd2602da24600d50c0712ce073ba55
http://europepmc.org/articles/PMC5523913
http://europepmc.org/articles/PMC5523913
Autor:
Omar Khwaja, Celine Risterucci, Oliver Bieri, Stefan Holiga, Ulrike Bonati, Wakana Tang, Alessandro Bertolino, Juergen Dukart, Dirk Fischer, Patricia Hafner, Alain Thoeni, Tobias Bergauer, Anne Marquet, Irene Gerlach, Christian Czech, Fabio Sambataro, Arne Fischmann, Nicole Hellbach
Publikováno v:
Annals of Clinical and Translational Neurology
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA) etiopathogenesis prompted development of potent intervention strategies and raised need for sensitive outcome measures capable of assessing disease progression and response to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7862154fefe58e7f412b90b21e97e030
https://doi.org/10.1002/acn3.406
https://doi.org/10.1002/acn3.406
Autor:
Irene Gerlach
Publikováno v:
Zeitschrift für Sozialreform. 63:27-36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::455c4a52b5f460b9ea8f455b8c23a1a1
https://doi.org/10.1515/zsr-2017-0004
https://doi.org/10.1515/zsr-2017-0004
Autor:
Tianle Yang, Hasane Ratni, Emmanuel Pinard, Nanjing Zhang, Hongyan Qi, Nikolai Naryshkin, Priya Vazirani, Stephan Kirchner, Xiaoyan Zhang, Karen S. Chen, Amal Dakka, Lutz Mueller, Friedrich Metzger, Woll Matthew G, Sergey Paushkin, Xin Zhao, Marla Weetall, Gary Mitchell Karp, Kathleen D. McCarthy, Agnès Poirier, Wolfgang Muster, Pascale David-Pierson, Luke Green, Irene Gerlach, Anthony Turpoff, Dietrich Tuerck
Publikováno v:
Journal of Medicinal Chemistry. 59:6086-6100
Spinal muscular atrophy (SMA) is the leading genetic cause of infant and toddler mortality, and there is currently no approved therapy available. SMA is caused by mutation or deletion of the survival motor neuron 1 (SMN1) gene. These mutations or del
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893761e5e7ae4b3161242bfe14378561
https://doi.org/10.1021/acs.jmedchem.6b00459
https://doi.org/10.1021/acs.jmedchem.6b00459
Autor:
Irene Gerlach
Publikováno v:
Zeitschrift für Sozialreform. 62:25-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fcfe3a5a07fc2659b7dcdd044636e68
https://doi.org/10.1515/zsr-2016-0004
https://doi.org/10.1515/zsr-2016-0004